Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Third intracellular loop of HCMV US28 is necessary for signaling and viral reactivation.

Autor: Medica S; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, USA., Denton M; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Diggins NL; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Kramer-Hansen O; Department of Biomedical Sciences Molecular Pharmacology, University of Copenhagen, Copenhagen, Denmark., Crawford LB; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Mayo AT; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Perez WD; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Daily MA; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Parkins CJ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Slind LE; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Pung LJ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Weber WC; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, USA., Jaeger HK; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Streblow ZJ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Sulgey G; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Kreklywich CN; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Alexander T; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Rosenkilde MM; Department of Biomedical Sciences Molecular Pharmacology, University of Copenhagen, Copenhagen, Denmark., Caposio P; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Hancock MH; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA., Streblow DN; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, USA.; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon, USA.; Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, USA.

Publikováno v: Journal of virology [J Virol] 2024 Dec 10, pp. e0180124. Date of Electronic Publication: 2024 Dec 10.